1324 related articles for article (PubMed ID: 31254236)
21. Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history.
Magrì S; Paduano D; Chicco F; Cingolani A; Farris C; Delogu G; Tumbarello F; Lai M; Melis A; Casula L; Fantini MC; Usai P
World J Gastroenterol; 2019 Oct; 25(37):5676-5686. PubMed ID: 31602167
[TBL] [Abstract][Full Text] [Related]
22. Non-alcoholic fatty liver disease is associated with bacterial translocation and a higher inflammation response in psoriatic patients.
Belinchón-Romero I; Bellot P; Romero-Pérez D; Herraiz-Romero I; Marco F; Frances R; Ramos-Rincón JM
Sci Rep; 2021 Apr; 11(1):8593. PubMed ID: 33883616
[TBL] [Abstract][Full Text] [Related]
23. Relevance of vitamin D on NAFLD and liver fibrosis detected by vibration controlled transient elastography in US adults: a cross-sectional analysis of NHANES 2017-2018.
Ji Y; Wei CB; Gu W; Hou LL
Ann Med; 2023 Dec; 55(1):2209335. PubMed ID: 37155562
[TBL] [Abstract][Full Text] [Related]
24. The triglyceride-glucose index is associated with the severity of hepatic steatosis and the presence of liver fibrosis in non-alcoholic fatty liver disease: a cross-sectional study in Chinese adults.
Guo W; Lu J; Qin P; Li X; Zhu W; Wu J; Xu N; Zhang Q
Lipids Health Dis; 2020 Oct; 19(1):218. PubMed ID: 33028338
[TBL] [Abstract][Full Text] [Related]
25. Clinical spectrum of non-alcoholic fatty liver disease in patients with diabetes mellitus.
Chen K; Sng WK; Quah JH; Liu J; Chong BY; Lee HK; Wang XF; Tan NC; Chang PE; Tan HC; Bee YM; Goh GBB
PLoS One; 2020; 15(8):e0236977. PubMed ID: 32822391
[TBL] [Abstract][Full Text] [Related]
26. Visceral adiposity in patients with psoriatic arthritis and psoriasis alone and its relationship with metabolic and cardiovascular risk.
Toussirot E; Aubin F; Desmarets M; Wendling D; Augé B; Gillard J; Messica O; Guillot X; Laheurte C; Monnet E; Dumoulin G
Rheumatology (Oxford); 2021 Jun; 60(6):2816-2825. PubMed ID: 33232483
[TBL] [Abstract][Full Text] [Related]
27. Psoriasis and Nonalcoholic Fatty Liver Disease.
Carrascosa JM; Bonanad C; Dauden E; Botella R; Olveira-Martín A;
Actas Dermosifiliogr; 2017; 108(6):506-514. PubMed ID: 28318525
[TBL] [Abstract][Full Text] [Related]
28. Ultrasound entheseal abnormalities at the distal interphalangeal joints and clinical nail involvement in patients with psoriasis and psoriatic arthritis, supporting the nail-enthesitis theory.
Acosta-Felquer ML; Ruta S; Rosa J; Marin J; Ferreyra-Garrot L; Galimberti ML; Galimberti R; Garcia-Monaco R; Soriano ER
Semin Arthritis Rheum; 2017 Dec; 47(3):338-342. PubMed ID: 28648658
[TBL] [Abstract][Full Text] [Related]
29. The increased prevalence of non-alcoholic fatty liver disease in psoriatic patients: a study from South India.
Madanagobalane S; Anandan S
Australas J Dermatol; 2012 Aug; 53(3):190-7. PubMed ID: 22672067
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and factors associated with NAFLD detected by vibration controlled transient elastography among US adults: Results from NHANES 2017-2018.
Zhang X; Heredia NI; Balakrishnan M; Thrift AP
PLoS One; 2021; 16(6):e0252164. PubMed ID: 34081733
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of non-alcoholic fatty liver and liver fibrosis in patients with moderate-severe psoriasis: A cross-sectional cohort study.
Magdaleno-Tapial J; Valenzuela-Oñate C; Ortiz-Salvador JM; Martínez-Doménech Á; García-Legaz-Martínez M; Alonso-Carpio M; Tamarit-García JJ; Diago-Madrid M; Sánchez-Carazo JL; Pérez-Ferriols A
Australas J Dermatol; 2020 May; 61(2):105-109. PubMed ID: 31731325
[TBL] [Abstract][Full Text] [Related]
32. Nonalcoholic fatty liver disease puts patients with psoriasis at greater cardiovascular risk.
Romero-Pérez D; Belinchón-Romero I; Bellot P; Francés R; Marco F; Ramos-Rincón JM
Australas J Dermatol; 2019 Nov; 60(4):e304-e310. PubMed ID: 31236937
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of non-alcoholic fatty liver disease (NAFLD) and its association with surrogate markers of insulin resistance in patients with type 1 diabetes.
de Vries M; Westerink J; El-Morabit F; Kaasjager HAHK; de Valk HW
Diabetes Res Clin Pract; 2022 Apr; 186():109827. PubMed ID: 35283265
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and Profile of Fibrosis in Diabetic Patients with Non-alcoholic Fatty Liver Disease and the Associated Factors.
Prasetya IB; Hasan I; Wisnu W; Rumende CM
Acta Med Indones; 2017 Apr; 49(2):91-98. PubMed ID: 28790222
[TBL] [Abstract][Full Text] [Related]
35. Non-Alcoholic Fatty Liver Disease Is Associated With Reduced Glomerular Filtration Rate in Patients With Chronic Plaque Psoriasis.
Bellinato F; Goio I; Malara G; Rosato A; Targher G; Girolomoni G; Gisondi P
J Cutan Med Surg; 2022; 26(3):249-255. PubMed ID: 34894782
[TBL] [Abstract][Full Text] [Related]
36. Non-alcoholic fatty liver disease (NAFLD) and significant hepatic fibrosis defined by non-invasive assessment in patients with type 2 diabetes.
Sobhonslidsuk A; Pulsombat A; Kaewdoung P; Petraksa S
Asian Pac J Cancer Prev; 2015; 16(5):1789-94. PubMed ID: 25773826
[TBL] [Abstract][Full Text] [Related]
37. Factors associated with significant liver steatosis and fibrosis as assessed by transient elastography in patients with one or more components of the metabolic syndrome.
Mikolasevic I; Milic S; Orlic L; Stimac D; Franjic N; Targher G
J Diabetes Complications; 2016; 30(7):1347-53. PubMed ID: 27324703
[TBL] [Abstract][Full Text] [Related]
38. Metabolic dysfunction-associated fatty liver disease improves detection of high liver stiffness: The Rotterdam Study.
van Kleef LA; Ayada I; Alferink LJM; Pan Q; de Knegt RJ
Hepatology; 2022 Feb; 75(2):419-429. PubMed ID: 34453359
[TBL] [Abstract][Full Text] [Related]
39. The burden of autoimmune disease: a comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis.
Makredes M; Robinson D; Bala M; Kimball AB
J Am Acad Dermatol; 2009 Sep; 61(3):405-10. PubMed ID: 19700012
[TBL] [Abstract][Full Text] [Related]
40. The Prevalence of Nonalcoholic Fatty Liver Disease and Related Metabolic Comorbidities Was Associated with Age at Onset of Moderate to Severe Plaque Psoriasis: A Cross-Sectional Study.
Xu X; Su L; Gao Y; Ding Y
PLoS One; 2017; 12(1):e0169952. PubMed ID: 28099469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
